Investing in Domestic & Chinese Small Cap Companies: Fred Astman & Scott Hood, First Wilshire Securities, Inc.

Tactical Investment Strategies: Kenneth R. Solow, Pinnacle Advisory Group, Inc.

Investing in Commercial Real Estate: Brian S. Brennan, Allianz of America, Inc.

Investing in Diabetes-Related Stocks: David A. Kliff, Diabetic Investor

Topics covered: Above average growth rates - Industry leaders - Companies with a defensible niche - Large cash positions - Expanding cash flows - Strong revenue growth - Experienced management teams - Sustainable competitive advantage - Companies headquartered in China with substantial operations in China - Pawnshop and payday loan operators - Korean and Chinese American banks - Reinsurance companies - Dynamic portfolio strategies - Asset allocation - Minimizing volatility - Yield component of commercial real estate - The diabetes care industry

Companies covered: Asta Funding (ASFI), Harbin Electric (HRBN), Jinpan (JST), China Housing & Land (CHLN), Fushi International (FSIN), China BAK Battery (CBAK), ABM Industries (ABM), Aspreva Pharmaceuticals (ASPV), RTW (RTWI), RenaissanceRe Holdings (RNR), Endurance Specialty Holdings (ENH), IMAX (IMAX), EZCORP (EZPW) First Cash (FCFS), Cash America (CSH), QC Holdings (QCCO), The Andersons (ANDE), BB Holdings (BBHLF), Amylin Pharmaceuticals (AMLN), Novo Nordisk (NOVO), Merck (MRK), Insulet (PODD), Becton Dickinson (BDX), CVS (CVS), Walgreen (WAG), Medco (MHS), SIRTRIS Pharmaceuticals (SIRT), and AgaMatrix.